Mary J. Ortner
Directeur Général chez Biophagy, Inc.
Postes actifs de Mary J. Ortner
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
Biophagy, Inc.
 Biophagy, Inc. Pharmaceuticals: MajorHealth Technology Biophagy, Inc. is an American biopharmaceutical company that manages standard drug development programs in several therapeutic areas. The company is also developing an OTC/DTC kit that focuses exclusively on autophagy stimulation and individual diagnostic measurement over an extended period. Biophagy's proprietary drug discovery program, CellWatch™, is being used to screen patented compounds in a variety of important disease indications to evaluate structure-activity relationships and develop leads. The company is headquartered at The BioScience Center and was founded by Stuart Rose. The CEO is Mary J. Ortner. | Directeur Général | - | - |
| President | - | - |
Historique de carrière de Mary J. Ortner
Anciens postes connus de Mary J. Ortner
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
SolaranRx, Inc.
 SolaranRx, Inc. BiotechnologyHealth Technology SolaranRx, Inc. develops therapies and companion imaging agents for the treatment of metastatic melanoma. It offers radiolabeled peptide that specifically binds to melanocortin-1 receptors on the surface of melanoma cells to identify patients suitable for treatment and to deliver targeted radiation potentially destroying receptor expressing tumors. The company was founded by Les Stewart and Stuart Rose in 2014 and is headquartered in Albuquerque, NM. | Corporate Officer/Principal | - | - |
Formation de Mary J. Ortner
| University of Hawai'i at Hilo | Doctorate Degree |
| California State University-Los Angeles | Graduate Degree |
| University of Connecticut | Masters Business Admin |
Statistiques
Internationale
| Etats-Unis | 6 |
Opérationnelle
| Corporate Officer/Principal | 1 |
| Doctorate Degree | 1 |
| Graduate Degree | 1 |
Sectorielle
| Consumer Services | 4 |
| Health Technology | 3 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Entreprise privées | 2 |
|---|---|
SolaranRx, Inc.
SolaranRx, Inc. BiotechnologyHealth Technology SolaranRx, Inc. develops therapies and companion imaging agents for the treatment of metastatic melanoma. It offers radiolabeled peptide that specifically binds to melanocortin-1 receptors on the surface of melanoma cells to identify patients suitable for treatment and to deliver targeted radiation potentially destroying receptor expressing tumors. The company was founded by Les Stewart and Stuart Rose in 2014 and is headquartered in Albuquerque, NM. | Health Technology |
Biophagy, Inc.
Biophagy, Inc. Pharmaceuticals: MajorHealth Technology Biophagy, Inc. is an American biopharmaceutical company that manages standard drug development programs in several therapeutic areas. The company is also developing an OTC/DTC kit that focuses exclusively on autophagy stimulation and individual diagnostic measurement over an extended period. Biophagy's proprietary drug discovery program, CellWatch™, is being used to screen patented compounds in a variety of important disease indications to evaluate structure-activity relationships and develop leads. The company is headquartered at The BioScience Center and was founded by Stuart Rose. The CEO is Mary J. Ortner. | Health Technology |
- Bourse
- Insiders
- Mary J. Ortner
- Expérience
